495 related articles for article (PubMed ID: 28471431)
1. Current application of CRISPR/Cas9 gene-editing technique to eradication of HIV/AIDS.
Huang Z; Tomitaka A; Raymond A; Nair M
Gene Ther; 2017 Jul; 24(7):377-384. PubMed ID: 28471431
[TBL] [Abstract][Full Text] [Related]
2. Application of CRISPR/Cas9-Based Gene Editing in HIV-1/AIDS Therapy.
Xiao Q; Guo D; Chen S
Front Cell Infect Microbiol; 2019; 9():69. PubMed ID: 30968001
[TBL] [Abstract][Full Text] [Related]
3. Genome editing strategies: potential tools for eradicating HIV-1/AIDS.
Khalili K; Kaminski R; Gordon J; Cosentino L; Hu W
J Neurovirol; 2015 Jun; 21(3):310-21. PubMed ID: 25716921
[TBL] [Abstract][Full Text] [Related]
4. [Application progress of CRISPR/Cas9 genome editing technology in the treatment of HIV-1 infection].
Han Y; Li QW
Yi Chuan; 2016 Jan; 38(1):9-16. PubMed ID: 26787519
[TBL] [Abstract][Full Text] [Related]
5. Updates on CRISPR-based gene editing in HIV-1/AIDS therapy.
Zhang Z; Hou W; Chen S
Virol Sin; 2022 Feb; 37(1):1-10. PubMed ID: 35234622
[TBL] [Abstract][Full Text] [Related]
6. Gene Editing With CRISPR/Cas9 RNA-Directed Nuclease.
Doetschman T; Georgieva T
Circ Res; 2017 Mar; 120(5):876-894. PubMed ID: 28254804
[TBL] [Abstract][Full Text] [Related]
7. CRISPR/Cas9-based tools for targeted genome editing and replication control of HBV.
Peng C; Lu M; Yang D
Virol Sin; 2015 Oct; 30(5):317-25. PubMed ID: 26511989
[TBL] [Abstract][Full Text] [Related]
8. [The application of CRISPR-Cas9 gene editing technology in viral infection diseases].
Yin LJ; Hu SQ; Guo F
Yi Chuan; 2015 May; 37(5):412-8. PubMed ID: 25998428
[TBL] [Abstract][Full Text] [Related]
9. A CRISPR/Cas9 guidance RNA screen platform for HIV provirus disruption and HIV/AIDS gene therapy in astrocytes.
Huang Z; Nair M
Sci Rep; 2017 Jul; 7(1):5955. PubMed ID: 28729655
[TBL] [Abstract][Full Text] [Related]
10. Application of CRISPR-Cas system in gene therapy: Pre-clinical progress in animal model.
Guan L; Han Y; Zhu S; Lin J
DNA Repair (Amst); 2016 Oct; 46():1-8. PubMed ID: 27519625
[TBL] [Abstract][Full Text] [Related]
11. Clustered regularly interspaced palindromic repeats-cas9-based strategies towards HIV eradication: A literature review.
Miranda AV; Wiyono L; Nurachman LA
J Pak Med Assoc; 2021 Feb; 71(Suppl 2)(2):S134-S139. PubMed ID: 33785958
[TBL] [Abstract][Full Text] [Related]
12. Delivery of CRISPR/Cas9 by Novel Strategies for Gene Therapy.
Wang L; Zheng W; Liu S; Li B; Jiang X
Chembiochem; 2019 Mar; 20(5):634-643. PubMed ID: 30393919
[TBL] [Abstract][Full Text] [Related]
13. The application of genome editing in studying hearing loss.
Zou B; Mittal R; Grati M; Lu Z; Shu Y; Tao Y; Feng Y; Xie D; Kong W; Yang S; Chen ZY; Liu X
Hear Res; 2015 Sep; 327():102-8. PubMed ID: 25987504
[TBL] [Abstract][Full Text] [Related]
14. CRISPR-Cas9 technology and its application in haematological disorders.
Zhang H; McCarty N
Br J Haematol; 2016 Oct; 175(2):208-225. PubMed ID: 27619566
[TBL] [Abstract][Full Text] [Related]
15. Application of CRISPR-Cas9 in eye disease.
Wu W; Tang L; D'Amore PA; Lei H
Exp Eye Res; 2017 Aug; 161():116-123. PubMed ID: 28619505
[TBL] [Abstract][Full Text] [Related]
16. The therapeutic application of CRISPR/Cas9 technologies for HIV.
Saayman S; Ali SA; Morris KV; Weinberg MS
Expert Opin Biol Ther; 2015 Jun; 15(6):819-30. PubMed ID: 25865334
[TBL] [Abstract][Full Text] [Related]
17. CRISPR-Cas9: a promising tool for gene editing on induced pluripotent stem cells.
Kim EJ; Kang KH; Ju JH
Korean J Intern Med; 2017 Jan; 32(1):42-61. PubMed ID: 28049282
[TBL] [Abstract][Full Text] [Related]
18. CRISPR-Cas9 gene editing: Delivery aspects and therapeutic potential.
Oude Blenke E; Evers MJ; Mastrobattista E; van der Oost J
J Control Release; 2016 Dec; 244(Pt B):139-148. PubMed ID: 27498021
[TBL] [Abstract][Full Text] [Related]
19. Advances in therapeutic CRISPR/Cas9 genome editing.
Savić N; Schwank G
Transl Res; 2016 Feb; 168():15-21. PubMed ID: 26470680
[TBL] [Abstract][Full Text] [Related]
20. A CRISPR-Cas Cure for HIV/AIDS.
Hussein M; Molina MA; Berkhout B; Herrera-Carrillo E
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
